enzon inc and eastman kodak eastman pharmaceuticals division said food and drug administration approved application allow clinical testing peg uricase drug proceed kodak owns pct enzon and owns marketing rights for peg uricase and two drugs enzon developing companies said peg uricase intended reduce uric acid levels patients undergoing chemotherapy and suffering from gout build uric acid bloodstream common side effect chemotherapy often leads kidney failure enzon said under fda new rules allow patients with life threatening diseases investigational drugs uric acid levels extremely ill patient decreased normal levels within hours after drug was injected separately said fda granted permission include unlimited number patients trials with peg ada drug used treat rare and usually fatal disease children called severe combined immuodeficiency said five children being treated with drug and hopes file new drug application peg ada 1987 when nda approved drug can marketed reuter 